Xuesha Liu

462 total citations
9 papers, 360 citations indexed

About

Xuesha Liu is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Xuesha Liu has authored 9 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Xuesha Liu's work include RNA modifications and cancer (3 papers), Cancer Mechanisms and Therapy (2 papers) and Signaling Pathways in Disease (2 papers). Xuesha Liu is often cited by papers focused on RNA modifications and cancer (3 papers), Cancer Mechanisms and Therapy (2 papers) and Signaling Pathways in Disease (2 papers). Xuesha Liu collaborates with scholars based in China, United States and Ethiopia. Xuesha Liu's co-authors include Yong Peng, Wenchen Pu, Lei Zhu, Jiankang Zhou, Lunxu Liu, Yuquan Wei, Juan He, Qiheng Gou, Yuanyuan Zheng and Xin Fan and has published in prestigious journals such as Hepatology, Cancer Research and Cell Death and Differentiation.

In The Last Decade

Xuesha Liu

8 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuesha Liu China	7	306	162	92	46	17	9	360
Wenfa Yu China	12	274 0.9×	182 1.1×	89 1.0×	39 0.8×	17 1.0×	17	370
Pol Margalef United Kingdom	10	317 1.0×	116 0.7×	94 1.0×	59 1.3×	12 0.7×	10	429
Ross Wanner United States	6	266 0.9×	197 1.2×	89 1.0×	63 1.4×	18 1.1×	13	365
Sara El‐Sahli Canada	8	232 0.8×	121 0.7×	125 1.4×	56 1.2×	41 2.4×	14	368
Elisa Pardella Italy	9	205 0.7×	130 0.8×	62 0.7×	46 1.0×	34 2.0×	15	323
Xiaobin Lv China	10	363 1.2×	237 1.5×	61 0.7×	42 0.9×	27 1.6×	11	456
Huacui Chen China	10	271 0.9×	195 1.2×	121 1.3×	58 1.3×	34 2.0×	12	399
Jianwei Liao China	8	213 0.7×	132 0.8×	98 1.1×	25 0.5×	21 1.2×	12	314
Daniel Senfter Austria	10	330 1.1×	233 1.4×	47 0.5×	46 1.0×	24 1.4×	19	417

Countries citing papers authored by Xuesha Liu

Since Specialization

Citations

This map shows the geographic impact of Xuesha Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuesha Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuesha Liu more than expected).

Fields of papers citing papers by Xuesha Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuesha Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuesha Liu. The network helps show where Xuesha Liu may publish in the future.

Co-authorship network of co-authors of Xuesha Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xuesha Liu. A scholar is included among the top collaborators of Xuesha Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuesha Liu. Xuesha Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Chen, Xi, et al.. (2025). Cyclin-dependent kinase 1 (CDK1) in cancers: from upstream regulation to downstream substrates and therapeutic inhibitors. European Journal of Medicinal Chemistry. 299. 118090–118090.

2.

Li, Zejiao, Xuesha Liu, Shijie Fan, et al.. (2025). The E3 ligase TRIM21 promotes progression of pancreatic ductal adenocarcinoma by down-regulating TAp63α and derepressing IL20RB. Science Signaling. 18(889). eadv4579–eadv4579. 1 indexed citations

3.

Liu, Xuesha, Wenchen Pu, Xin Fan, et al.. (2019). Novel ROR1 inhibitor ARI-1 suppresses the development of non-small cell lung cancer. Cancer Letters. 458. 76–85. 29 indexed citations

4.

Liu, Xuesha, Shunli Wan, Xin Fan, et al.. (2019). Discovery of Coumarin as Microtubule Affinity-Regulating Kinase 4 Inhibitor That Sensitize Hepatocellular Carcinoma to Paclitaxel. Frontiers in Chemistry. 7. 366–366. 19 indexed citations

5.

Gou, Qiheng, Linbo Gao, Wenchen Pu, et al.. (2018). Long Noncoding RNA AB074169 Inhibits Cell Proliferation via Modulation of KHSRP-Mediated CDKN1a Expression in Papillary Thyroid Carcinoma. Cancer Research. 78(15). 4163–4174. 78 indexed citations

6.

Li, Jiao, Wenchen Pu, Hui‐Lung Sun, et al.. (2018). Pin1 impairs microRNA biogenesis by mediating conformation change of XPO5 in hepatocellular carcinoma. Cell Death and Differentiation. 25(9). 1612–1624. 42 indexed citations

7.

Pu, Wenchen, Jiao Li, Yuanyuan Zheng, et al.. (2018). Targeting Pin1 by inhibitor API‐1 regulates microRNA biogenesis and suppresses hepatocellular carcinoma development. Hepatology. 68(2). 547–560. 66 indexed citations

8.

Zhu, Lei, Xuesha Liu, Wenchen Pu, & Yong Peng. (2018). tRNA-derived small non-coding RNAs in human disease. Cancer Letters. 419. 1–7. 74 indexed citations

9.

Zhou, Jiankang, Yuzhu Zheng, Xuesha Liu, et al.. (2017). ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer. Oncotarget. 8(20). 32864–32872. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact